Kelly Honohan

Kelly Honohan is an accomplished legal professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as General Counsel at Solu Therapeutics since September 2023, Kelly also operates as Principal at KNH Consulting, LLC since August 2015. Previous roles include General Counsel at Faze Medicines from March 2021 to February 2023, General Counsel & Company Secretary at Northern Biologics from April 2018 to March 2021, and VP, Legal Counsel at Shire Pharmaceuticals from January 2006 to August 2015. Additionally, Kelly has held positions as Legal Counsel at Bristol-Myers Squibb (2003-2005) and as an Associate at Ropes & Gray LLP (2001-2003).